Switch to:

Arrowhead Pharmaceuticals EV-to-EBIT

: -125.79 (As of Today)
View and export this data going back to 1997. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arrowhead Pharmaceuticals's Enterprise Value is $4,201.4 Mil. Arrowhead Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-33.4 Mil. Therefore, Arrowhead Pharmaceuticals's EV-to-EBIT for today is -125.79.

NAS:ARWR' s EV-to-EBIT Range Over the Past 10 Years
Min: -141.5   Med: -3.6   Max: 3207.7
Current: -125.78

-141.5
3207.7

During the past 13 years, the highest EV-to-EBIT of Arrowhead Pharmaceuticals was 3207.70. The lowest was -141.50. And the median was -3.60.

NAS:ARWR's EV-to-EBIT is ranked lower than
99.99% of the 245 Companies
in the Biotechnology industry.

( Industry Median: 31.19 vs. NAS:ARWR: -125.78 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Arrowhead Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2020 was $4,150.0 Mil. Arrowhead Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-33.4 Mil. Arrowhead Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 was -0.80%.


Arrowhead Pharmaceuticals EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.55 -5.39 -7.03 -28.99 39.75

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.60 39.75 130.55 2,308.49 -124.25

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arrowhead Pharmaceuticals EV-to-EBIT Distribution

* The bar in red indicates where Arrowhead Pharmaceuticals's EV-to-EBIT falls into.



Arrowhead Pharmaceuticals EV-to-EBIT Calculation

Arrowhead Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4201.405/-33.401
=-125.79

Arrowhead Pharmaceuticals's current Enterprise Value is $4,201.4 Mil.
Arrowhead Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was 9.638 (Sep. 2019 ) + -4.853 (Dec. 2019 ) + -22.24 (Mar. 2020 ) + -15.946 (Jun. 2020 ) = $-33.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals  (NAS:ARWR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Arrowhead Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2020 ) =EBIT / Enterprise Value (Q: Jun. 2020 )
=-33.401/4150.00569
=-0.80 %

Arrowhead Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2020 was $4,150.0 Mil.
Arrowhead Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was 9.638 (Sep. 2019 ) + -4.853 (Dec. 2019 ) + -22.24 (Mar. 2020 ) + -15.946 (Jun. 2020 ) = $-33.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals EV-to-EBIT Related Terms


Arrowhead Pharmaceuticals EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)